Constellation Energy (CEG) Is Down 11.6% After Calpine-Fueled Q1 Earnings Surge And Data Center Deals – Has The Bull Case Changed?

Constellation Energy Corporation

Constellation Energy Corporation

CEG

0.00

  • Constellation Energy’s first-quarter 2026 results, reported in May, showed sales of US$11.12 billion and net income of US$1.59 billion, with earnings per share rising sharply year over year, largely reflecting the completed Calpine acquisition.
  • By pairing this earnings surge with expanded clean-energy projects, renewable natural gas investments, and large data center power contracts, Constellation is reinforcing its role as a major low-carbon power supplier to hyperscalers and other large consumers.
  • We’ll now examine how this earnings jump driven by the Calpine acquisition may influence Constellation Energy’s existing investment narrative.

Capitalize on the AI infrastructure supercycle with our selection of the 41 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Constellation Energy Investment Narrative Recap

To own Constellation Energy, you need to believe that demand for long-duration, low carbon power from data centers and large corporates will keep supporting premium contracts, and that management can integrate Calpine without undermining that thesis. The Q1 2026 earnings spike, heavily influenced by the Calpine deal, strengthens the near term catalyst of data center contract wins, but also sharpens the key risk: execution and regulatory delays around complex nuclear and grid projects like Crane.

Among recent developments, the agreement to acquire a minority interest in Pine Creek’s renewable natural gas facilities is especially relevant. It shows Constellation extending its low carbon offering beyond nuclear at the same time Calpine’s gas and solar assets bulk up its portfolio. Together, these moves could matter for winning new 24/7 carbon free power deals with hyperscalers, but they also add project and integration complexity on top of already tight grid and regulatory timelines.

Yet even with all this momentum, investors should still pay close attention to the growing regulatory and interconnection risks around key nuclear assets...

Constellation Energy's narrative projects $35.1 billion revenue and $5.8 billion earnings by 2029. This requires 11.2% yearly revenue growth and a $3.5 billion earnings increase from $2.3 billion.

Uncover how Constellation Energy's forecasts yield a $370.58 fair value, a 35% upside to its current price.

Exploring Other Perspectives

CEG 1-Year Stock Price Chart
CEG 1-Year Stock Price Chart

The most bullish analysts already expected Constellation to reach about US$44.6 billion of revenue and US$7.9 billion of earnings by 2029, so if you think AI driven power demand and premium data center contracts will accelerate faster than consensus, this upbeat view looks appealing, but the latest Calpine boosted results and nuclear project uncertainties could easily shift how realistic those assumptions and risks now appear.

Explore 10 other fair value estimates on Constellation Energy - why the stock might be worth as much as 74% more than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your Constellation Energy research is our analysis highlighting 4 key rewards and 3 important warning signs that could impact your investment decision.
  • Our free Constellation Energy research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Constellation Energy's overall financial health at a glance.

Searching For A Fresh Perspective?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

  • Invest in the nuclear renaissance through our list of 87 elite nuclear energy infrastructure plays powering the global AI revolution.
  • AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
  • Find 47 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.